Get started
Author

Janet Ayello

Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation.
1998 · C Hesdorffer, J Ayello, et al. · Journal of Clinical Oncology · 214
Targeting CD20+ Aggressive B-cell Non–Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice
2014 · Yaya Chu, Jessica Hochberg, et al. · Cancer Immunology Research · 174
Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20+ rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic leukaemia
2015 · Aradhana Awasthi, Janet Ayello, et al. · British Journal of Haematology · 95
PDF
Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice
2017 · Yaya Chu, Ashlin Yahr, et al. · OncoImmunology · 82
PDF
Safety, Pharmacokinetics, and Immunomodulatory Effects of Lenalidomide in Children and Adolescents With Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome: A Children's Oncology Group Phase I Consortium Report
2010 · Stacey L. Berg, Mitchell S. Cairo, et al. · Journal of Clinical Oncology · 62
An Age-Dependent Pharmacokinetic Study of Intravenous and Oral Mycophenolate Mofetil in Combination with Tacrolimus for GVHD Prophylaxis in Pediatric Allogeneic Stem Cell Transplantation Recipients
2009 · Monica Bhatia, Olga Militano, et al. · Transplantation and Cellular Therapy · 56
Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis
2017 · W Luo, C Xu, et al. · Oncogene · 50
Ex vivo expansion, maturation, and activation of umbilical cord blood–derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7
2002 · Kathleen L Robinson, Janet Ayello, et al. · Experimental Hematology · 46
ABSTRACTS
2022 · Milner, J, Talano, J A, et al. · Pediatric Blood & Cancer · 43
The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL
2017 · Sanghoon Lee, Wen Luo, et al. · Oncotarget · 35
PDF
T cell depletion utilizing CD 34+ stem cell selection and CD 3+ addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients
2012 · Mark B. Geyer, Angela M. Ricci, et al. · British Journal of Haematology · 35
PDF
Characterization of natural killer and natural killer–like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: Implications for adoptive cellular immunotherapy
2009 · Janet Ayello, Carmella van de Ven, et al. · Experimental Hematology · 34
Characterization of Cord Blood Natural Killer and Lymphokine Activated Killer Lymphocytes Following Ex Vivo Cellular Engineering
2006 · Janet Ayello, Carmella van de Ven, et al. · Transplantation and Cellular Therapy · 34
PDF
A Phase I Study of 90Yttrium-Ibritumomab-Tiuxetan in Children and Adolescents with Relapsed/Refractory CD20-Positive Non–Hodgkin's Lymphoma: A Children's Oncology Group Study
2007 · Erin Cooney-Qualter, Mark Krailo, et al. · Clinical Cancer Research · 33
Targeting Glutathione S-transferase M4 in Ewing sarcoma
2014 · Rupeng Zhuo, Kenneth M. Kosak, et al. · Frontiers in Pediatrics · 31
PDF
Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity
2014 · Prakash Satwani, Sejal Bavishi, et al. · Cytotherapy · 29
Effects of Long-Term Storage at -90°C of Bone Marrow and PBPC on Cell Recovery, Viability, and Clonogenic Potential
1998 · J. AYELLO, M. SEMIDEI-POMALES, et al. · Journal of Hematotherapy · 29
Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.
1998 · L T Vahdat, K Papadopoulos, et al. · PubMed · 29
Harvest Quality and Factors Affecting Collection and Engraftment of CD34+ Cells in Patients with Breast Cancer Scheduled for High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Support
1997 · K.P. PAPADOPOULOS, J. AYELLO, et al. · Journal of Hematotherapy · 26
Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function
2011 · Prakash Satwani, Carmella van de Ven, et al. · Cytotherapy · 25
Retroviral transfer and expression of the human multiple drug resistance (MDR) gene in peripheral blood progenitor cells.
1996 · M Ward, P Pioli, et al. · PubMed · 25
Ruxolitinib significantly enhances in vitro apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine model
2018 · Sanghoon Lee, Tishi Shah, et al. · Oncotarget · 24
PDF
Rescue of the Mucocutaneous Manifestations by Human Cord Blood Derived Nonhematopoietic Stem Cells in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa
2015 · Yanling Liao, Larisa Ivanova, et al. · Stem Cells · 24
PDF
Marrow Storage Techniques: A Clinical Comparison of Refrigeration versus Cryopreservation
2009 · Tauseef Ahmed, David Wuest, et al. · Acta Haematologica · 24
Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy
2016 · Janet Ayello, Jessica Hochberg, et al. · Experimental Hematology · 23
PDF
Works count: 284
Citation count: 1,810
H-index: 24
I10-index: 43
Year
Topic
Type